Avastin is indicated for the treatment of patients who have not received chemotherapy for metastatic HER2 negative breast cancer in combination with paclitaxel.

Avastin, in combination with carboplatin and paclitaxel, followed by Avastin as a single agent, is indicated for the treatment of patients with stage III or IV epithelial ovarian, fallopian tube, or primary peritoneal cancer following initial surgical resection.

Avastin, in combination with fluoropyrimidine-irinotecan- or fluoropyrimidine-oxaliplatin-based chemotherapy, is indicated for the second-line treatment of patients with metastatic colorectal...

Avastin, in combination with carboplatin and paclitaxel, is indicated for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non–squamous non–small...

Avastin, in combination with carboplatin and paclitaxel, or with carboplatin and gemcitabine, followed by Avastin as a single agent, is indicated for the treatment of patients with platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.

Avastin, in combination with carboplatin and paclitaxel, is indicated for the first-line treatment of patients with unresectable, locally advanced, recurrent or metastatic non–squamous non–small cell lung cancer (NSCLC). Avastin is indicated for the …

AVASTIN is an antineoplastic agent containing the active ingredient, bevacizumab. Bevacizumab is a recombinant humanised monoclonal antibody that selectively binds to and neutralises the biologic activity of human vascular endothelial growth factor (VEGF).

Avastin, in combination with paclitaxel, pegylated liposomal doxorubicin, or topotecan, is indicated for the treatment of patients with platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal

AVASTIN是一种阻碍血管生成的药物，通过抑制血管内皮生长因子（VEGF）的作用阻断对肿瘤的血液供应，阻止或减缓肿瘤的生长，增强化疗效果。 批准基于GOG-0218（NCT00262847），这是一项多中心，随机，双盲，安慰剂对照，三臂实验研究，评估对于AVASTIN的加入，卡铂和紫杉醇用于III或IV期卵巢上皮性、输卵管性或初次手术切除后的原发性腹膜癌治疗效果的影响。 1873位患者被随机平均分到三组，分别为只加卡铂和紫杉醇而不使用AVASTIN 、卡铂和紫杉醇联 …

Avastin (bevacizumab) in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of patients with metastatic carcinoma of the colon or rectum. Avastin in combination with paclitaxel or docetaxel is indicated for first-line treatment of …